KMDA
Kamada LtdRecent alerts on KMDA
All signals →
SEC filing
KMDA Receives FDA Approval for In-House Rabies Virus Neutralization Testing Laboratory, Expands Testing Capabilities for KEDRAB and KAMRAB Products
1d ago
SEC filing
KMDA Reports $45.2M Revenue, $4.1M Net Income, $0.07 EPS, Guides $200-205M 2026
20d ago
SEC filing
KMDA FDA Approves San Antonio Plasma Center, 50K Liters Capacity, $8-10M Revenue
68d ago
SEC filing
KMDA Reports $0 Revenue, $0 EPS, No Deals, No Growth Metrics
76d ago
SEC filing
KMDA Declares $0.25 Cash Dividend, $14.4M Payout, Record FY2025 Revenue & Profitability
83d ago
News
Kamada forecasts double-digit profitable growth in 2026
145d ago
Get push alerts for KMDA
Add it to your watchlist in the app and receive every signal the moment it fires.
Download for iOS